↑"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
↑"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
↑Cawthon RM, Andersen LB, Buchberg AM, Xu GF, O'Connell P, Viskochil D, Weiss RB, Wallace MR, Marchuk DA, Culver M, etal. (Jun 1991). "cDNA sequence and genomic structure of EV12B, a gene lying within an intron of the neurofibromatosis type 1 gene". Genomics. 9 (3): 446–60. doi:10.1016/0888-7543(91)90410-G. hdl:2027.42/29439. PMID1903357.
Xu G, O'Connell P, Stevens J, White R (1992). "Characterization of human adenylate kinase 3 (AK3) cDNA and mapping of the AK3 pseudogene to an intron of the NF1 gene". Genomics. 13 (3): 537–42. doi:10.1016/0888-7543(92)90122-9. PMID1639383.
Cawthon RM, Weiss R, Xu GF, etal. (1990). "A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations". Cell. 62 (1): 193–201. doi:10.1016/0092-8674(90)90253-B. PMID2114220. S2CID8201518.
Douglas J, Cilliers D, Coleman K, etal. (2007). "Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth". Nat. Genet. 39 (8): 963–5. doi:10.1038/ng2083. hdl:2381/22044. PMID17632510. S2CID35797973.